Seer: Q1 Earnings Insights

Seer (NASDAQ:SEER) reported its Q1 earnings results on Tuesday, May 9, 2023 at 04:05 PM. Here’s what investors…

Seer (NASDAQ:SEER) reported its Q1 earnings results on Tuesday, May 9, 2023 at 04:05 PM.

Here’s what investors need to know about the announcement.

Earnings

Seer reported in-line EPS of $-0.38 versus an estimate of $-0.38.

Revenue was up $741 thousand from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.07 which was followed by a 29.45% increase in the share price the next day.

Here’s a look at Seer’s past performance:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate -0.43 -0.39 -0.39 -0.40
EPS Actual -0.36 -0.38 -0.37 -0.38
Revenue Estimate 3.87M 3.51M 3.26M 2.35M
Revenue Actual 4.60M 3.96M 3.62M 3.31M

To track all earnings releases for Seer visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Amicus Therapeutics Reports Preliminary 2023 Revenue And Provides 2024 Strategic Outlook; Q4 Revenue ~$115.1M Vs $112.25M Est.; Sees FY23 Revenue Of ~$399.4M Vs $396.45M Est.; Co Sees FY24 As First Full Year Of Achieving Non-GAAP Profitability

Bradley Campbell, President and Chief Executive Officer of Amicus Therapeutics, Inc., stated, "Last year was an incredible year for Amicus highlighted by the continued double-digit growth of Galafold sales and the global

FOLD